AstraZeneca Sells Gastro Treatment to Swiss Group Tillotts

13.07.2015 - In another move to sharpen its focus on oncology, diabetes and respiratory disorders, AstraZeneca has announced it is selling all non-US rights for Entocort, a treatment for Crohn...